Trending Down-0.3400 (-1.8085%)
  • Bid / Lots
    18.4000/ 1
  • Ask / Lots
    18.4600/ 2
  • Open / Previous Close
    18.8600 / 18.8000
  • Day Range
    Low 18.3250
    High 19.2700
  • 52 Week Range
    Low 3.6000
    High 28.1500
  • Volume

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 18.8
09:32 ET207918.77
09:34 ET20118.995
09:38 ET10019.27
09:39 ET20019.035
09:41 ET550018.8865
09:43 ET40218.635
09:50 ET203618.96
09:52 ET49218.9
09:54 ET10018.86
09:56 ET20018.79
09:57 ET10018.78
09:59 ET10018.84
10:01 ET10018.83
10:03 ET20018.7
10:06 ET250018.42
10:08 ET240618.4325
10:10 ET343418.5
10:12 ET80518.475
10:14 ET10018.475
10:15 ET362418.68
10:17 ET10018.705
10:19 ET41218.65
10:21 ET70018.675
10:24 ET240018.645
10:26 ET416518.62
10:28 ET132418.63
10:30 ET23818.68
10:32 ET90018.55
10:35 ET10018.65
10:37 ET121418.61
10:44 ET558918.535
10:46 ET60018.48
10:53 ET10018.5
10:55 ET10018.385
10:57 ET10018.51
11:04 ET20018.455
11:06 ET30018.47
11:08 ET10018.47
11:09 ET120018.405
11:11 ET90018.35
11:15 ET20018.44
11:18 ET21018.44
11:20 ET20018.56
11:22 ET20018.55
11:26 ET20018.57
11:27 ET10018.585
11:33 ET57518.65
11:36 ET10018.625
11:38 ET180018.49
11:42 ET100018.44
11:44 ET30018.43
11:49 ET10018.395
11:51 ET10018.4
11:54 ET10018.445
11:58 ET118718.44
12:00 ET24218.44
12:03 ET64618.44
12:05 ET40018.44
12:07 ET10018.44
12:09 ET10018.455
12:12 ET10018.455
12:14 ET130018.46
12:20 ET90018.46
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLBPH
Longboard Pharmaceuticals Inc
United StatesGHRS
GH Research PLC
United StatesLYEL
Lyell Immunopharma Inc
United StatesNUVB
Nuvation Bio Inc
United StatesPRAX
Praxis Precision Medicines Inc
United StatesVRDN
Viridian Therapeutics Inc
As of 2024-05-28

Company Information

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for neurological diseases. The Company is working to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). It is focused on developing various product candidates in its pipeline, which includes bexicaserin (LP352) and LP659. The Company plans to advance bexicaserin (LP352), an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with no observed impact on 5-HT2B and 5-HT2A receptor subtypes, into a global Phase 3 program. It is also evaluating LP659, an oral, centrally acting, sphingosine-1-phosphate (S1P) receptor subtypes 1 and 5 modulator, which is in development for the potential treatment of rare neuroinflammatory conditions. The Company is conducting a Phase 1 single-ascending dose (SAD) clinical trial for LP659 in healthy volunteers.

Contact Information

4275 Executive Square, Suite 950LA JOLLA, CA, United States 92037


Independent Chairman of the Board
Paul Sekhri
President, Chief Executive Officer, Director
Kevin Lind
Chief Financial Officer, Executive Vice President
Brandi Roberts
Executive Vice President, Chief Medical Officer
Randall Kaye
Independent Director
Vincent Aurentz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.